ARIAD Pharma (ARIA) Announces U.S. FDA Acceptanct of Brigatinib NDA; Request for Priority Review Granted
Go back to ARIAD Pharma (ARIA) Announces U.S. FDA Acceptanct of Brigatinib NDA; Request for Priority Review GrantedAriad Pharmaceuticals, Inc. (NASDAQ: ARIA) | Delayed: 23.99 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $23.99 | 52 Week High | $14.34 | |||
Open | $3.07 | 52 Week Low | $4.37 | |||
Day High | $23.99 | P/E | N/A | |||
Day Low | $23.99 | EPS | $-1.45 | |||
Volume | 208,921 |